drug:wegovy Less for Less: CVS drops Zepbound for Wegovy CVS Health drops coverage of the more effective Tirzepatide (Zepbound) for Semaglutide (Ozempic, Wegovy) and Liraglutide (Saxenda).
drug:orforglipron Updates from MariTide & Orforglipron research MariTide and Orfoglipron updates from the ADA 85th Science Sessions conference in June, with the key results that were announced.
category:news A challenge to Eli Lilly's Tirzepatide patent Empower Pharmacy has challenged the patent on Eli Lilly's Tirzepatide, creating possibly the biggest possible shock to come to compounding GLP1s.
drug:eloralinitide Amylin, with and without GLP1: Eloralinitide We dig into early results around Eloralinitide, an amylin-based weight loss formulation being developed by Eli Lilly.
company:eli-lilly Eli Lilly's big Summer 2025 update We take a look at some exciting upcoming presentations by Eli Lilly about it's old and new GLP1 receptor agonists.
drug:retatrutide An update on Retatrutide (May 2025) We take some time to check in on Retatrutide -- an update on how research and trials are progressing, and relevant news.
company:eli-lilly Eli Lilly suing GLP1 compounders & related companies Eli Lilly sues many compounding-related companies in an effort to clear the market of compounded GLP1.
category:news Oral pill Orforglipron delivers stellar results in Phase 3 Trial Eli Lilly's new drug oral GLP1 Orforglipron delivers fantastic results in phase 3 trial -- 7.6% weight loss for just a pill!
politics 2025 Trump Tariffs on Pharmaceutical Imports Trump announces soon-to-be tariffs on pharmaceutical imports, we dig into how much Novo Nordisk and Eli Lilly could be affected.
category:news Hims pivots to branded Tirzepatide, generic Liraglutide Hims changes to selling branded Tirzepatide along with the Liraglutide generic on their telehealth platform, after the shortage ends.
category:watercooler Shortages threaten corporate profits, likely to end soon We think the GLP1 shortage is going to end in the first half of 2025. Here's why.
category:howto What's the best injection site for GLP1s? What's the best site for injecting Ozempic, Wegovy, Mounjaro, or Zepbound? We check anecdata, manufacturers, and 3rd parties.
category:benefits Zepbound coverage for Sleep Apnea gets Agency approval Center for Medicare and Medicaid declared that Zepbound is covered by insurance for treating Sleep Apnea, given it's effectiveness.
company:eli-lilly Eli Lilly brands GLP1s as "anti-hedonics" Eli Lilly leans into the use of GLP1s for reducing addictive behavior, labeling them "anti-hedonics"
category:news FDA reconsidering Tirzepatide shortage list removal After legal action by a group of compounders, the FDA is reviewing their removal of Tirzepatide (Mounjaro, Zepbound) from the shortage list.
category:news Compounders sue FDA over Tirzepatide shortage changes Compounders sue FDA for removing Eli Lilly's weight loss drug from the shortage list. Does the case have legs?
category:news Why the Tirzepatide shortage ending might be bad news. Bad news that sounds like good news: FDA ends shortage Eli Lilly's GLP-1 (Tirzepatide). We'll tell you why that's bad news.
company:eli-lilly Eli Lilly's other new GLP1 - Orforglipron Eli Lilly is developing new GLP1 drugs, and Orforglipron is one of them. It's not easy to pronounce, but it is easy to take, and easy to produce.
company:eli-lilly Eli Lilly China approval and new suppliers As the race to manufacture more GLP1 medications intensifies, Eli Lilly gets approval in China and more suppliers.
